Stig Egil Bojesen

Stig Egil Bojesen's AcademicInfluence.com Rankings

Stig Egil Bojesen

Communications

#6825

World Rank

#9361

Historical Rank

Linguistics

#1193

World Rank

#1507

Historical Rank

communications Degrees

Download Badge

Communications

Stig Egil Bojesen's Degrees

PhD Linguistics Aarhus University
Masters Linguistics Aarhus University
Bachelors Linguistics Aarhus University

Why Is Stig Egil Bojesen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stig Egil Bojesen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genome-wide association study identifies novel breast cancer susceptibility loci (2007) (2351)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
Statin use and reduced cancer-related mortality. (2012) (736)
A common coding variant in CASP8 is associated with breast cancer risk (2007) (591)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021) (585)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array (2012) (550)
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. (2007) (525)
Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study (2017) (425)
Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. (2009) (400)
MicroRNA biomarkers in whole blood for detection of pancreatic cancer. (2013) (398)
Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics (2008) (390)
RAD51B in Familial Breast Cancer (2016) (366)
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk (2017) (359)
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes (2017) (353)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) (308)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study (2011) (295)
Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. (2008) (287)
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers (2016) (267)
Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. (2013) (255)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts (2014) (240)
Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population. (2015) (234)
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) (205)
Short telomere length, cancer survival, and cancer risk in 47102 individuals. (2013) (198)
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
Identification of Novel Genetic Markers of Breast Cancer Survival (2015) (185)
Short Telomere Length, Myocardial Infarction, Ischemic Heart Disease, and Early Death (2012) (182)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. (2012) (164)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia (2014) (159)
Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors (2013) (159)
Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study. (2014) (158)
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
Telomere Shortening Unrelated to Smoking, Body Weight, Physical Activity, and Alcohol Intake: 4,576 General Population Individuals with Repeat Measurements 10 Years Apart (2014) (149)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals (2012) (140)
The link between benign prostatic hyperplasia and prostate cancer (2013) (139)
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants (2020) (138)
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study (2012) (137)
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study (2011) (134)
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. (2013) (131)
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. (2000) (130)
A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk (2013) (125)
Increased risk of breast cancer associated with CHEK2*1100delC. (2006) (123)
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk (2013) (120)
Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population (2007) (119)
C-reactive protein and the risk of cancer: a mendelian randomization study. (2010) (117)
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (2009) (116)
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
Plasma YKL-40 levels in healthy subjects from the general population. (2011) (108)
AHRR (cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality (2017) (107)
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
The JAK2 V617F somatic mutation, mortality and cancer risk in the general population (2011) (105)
Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV (2014) (104)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
Telomeres and human health (2013) (103)
Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study (2018) (102)
Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (2008) (100)
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression (2013) (100)
Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. (2011) (98)
Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. (2013) (95)
Association of ESR1 gene tagging SNPs with breast cancer risk. (2009) (95)
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study. (2016) (90)
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
The common germline Arg72Pro polymorphism of p53 and increased longevity in humans (2008) (88)
Increased body mass index, elevated C-reactive protein, and short telomere length. (2014) (87)
Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. (2009) (87)
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. (2018) (86)
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population (2013) (86)
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. (2018) (86)
Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals. (2016) (83)
Detection and characterization of lung cancer using cell-free DNA fragmentomes (2021) (83)
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
Smoking and Increased White and Red Blood Cells: A Mendelian Randomization Approach in the Copenhagen General Population Study (2019) (83)
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia (2001) (83)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease (2013) (77)
Long telomeres and cancer risk among 95 568 individuals from the general population. (2016) (76)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. (2016) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
Genetic modifiers of CHEK2*1100delC associated breast cancer risk (2016) (68)
JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate (2014) (68)
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
Shared heritability and functional enrichment across six solid cancers (2018) (67)
Risk of cancer by ATM missense mutations in the general population. (2008) (67)
Integrin β3 Leu33Pro Homozygosity and Risk of Cancer (2003) (66)
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population (2016) (65)
Elevated plasma YKL‐40 levels and ischemic stroke in the general population (2010) (63)
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
Plasma YKL-40 and total and disease-specific mortality in the general population. (2010) (62)
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: Cross‐sectional and prospective studies and meta‐analyses of 75,000 cases and 93,000 controls (2011) (62)
Genome-wide association study identifies a novel variant in RAD51B associated with male breast cancer risk (2012) (61)
Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. (2010) (56)
Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study. (2011) (56)
Shorter leukocyte telomere length is associated with higher risk of infections: a prospective study of 75,309 individuals from the general population (2017) (54)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
Platelet glycoprotein IIb/IIIa PlA2/PlA2homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: The Copenhagen City Heart Study (2003) (52)
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk (2018) (51)
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2015) (50)
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
Plasma 25-hydroxyvitamin D and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. (2013) (49)
Associations between first and second primary cancers: a population-based study (2012) (49)
Secular trends in smoking in relation to prevalent and incident smoking-related disease: A prospective population-based study (2019) (46)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
DNA mismatch repair gene MSH6 implicated in determining age at natural menopause (2013) (44)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
CHRNA3 genotype, nicotine dependence, lung function and disease in the general population (2012) (44)
Is high vitamin B12 status a cause of lung cancer? (2019) (44)
Integrin beta3 Leu33Pro homozygosity and risk of cancer. (2003) (44)
High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55,568 individuals, but not with short telomeres: a Mendelian randomization study. (2014) (43)
Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population (2011) (43)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
Appraising the causal relevance of DNA methylation for risk of lung cancer (2018) (41)
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
Elevated Plasma YKL-40, Lipids and Lipoproteins, and Ischemic Vascular Disease in the General Population (2015) (40)
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases (2016) (39)
Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2009) (39)
Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) (38)
Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
IgE and risk of cancer in 37 747 individuals from the general population. (2015) (37)
Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity (2018) (37)
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization (2020) (37)
Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population (2011) (36)
Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases (2014) (36)
Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study (2019) (36)
Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) (35)
Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (35)
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer (2016) (33)
Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study. (2014) (33)
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions (2014) (33)
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
AHRR hypomethylation, lung function, lung function decline and respiratory symptoms (2018) (32)
Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer (2020) (32)
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. (2012) (32)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
Common germline polymorphisms associated with breast cancer-specific survival (2015) (31)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
Long-term prostate-specific antigen velocity in improved classification of prostate cancer risk and mortality. (2013) (30)
Telomere length and depression: Prospective cohort study and Mendelian randomisation study in 67 306 individuals (2017) (30)
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight (2020) (30)
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer (2013) (29)
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome (2006) (27)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) (27)
Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer (2007) (27)
Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model (2021) (26)
Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2·3 million people (2019) (26)
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population (2018) (25)
Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk (2015) (25)
Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52 000 individuals (2009) (25)
Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners (2018) (25)
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. (2012) (24)
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium (2012) (24)
Smoking does not accelerate leucocyte telomere attrition: a meta-analysis of 18 longitudinal cohorts (2019) (24)
C-reactive Protein as a Predictor of Prognosis in COPD. (2006) (24)
Observational and genetic studies of short telomeres and Alzheimer’s disease in 67,000 and 152,000 individuals: a Mendelian randomization study (2019) (24)
Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats. (2017) (23)
Association of ESR 1 gene tagging SNPs with breast cancer risk (2009) (23)
Asthma, other atopic conditions and risk of infections in 105 519 general population never and ever smokers (2017) (23)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (22)
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development (2019) (21)
Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. (2018) (21)
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis. (2012) (21)
Risk of Breast Cancer in Relation to Combined Effects of Hormone Therapy, Body Mass Index, and Alcohol Use, by Hormone-receptor Status (2015) (20)
Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. (2003) (20)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (20)
Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals (2020) (20)
Observational and genetic plasma YKL‐40 and cancer in 96,099 individuals from the general population (2015) (20)
CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50 000 individuals (2009) (20)
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis (2019) (20)
Transcriptome‐wide association study reveals candidate causal genes for lung cancer (2018) (19)
Breast cancer risk factors and their effects on survival: a Mendelian randomisation study (2020) (19)
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. (2019) (19)
Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium (2017) (19)
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies. (2014) (18)
Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population (2013) (17)
Loss-of-function polymorphism in IL6R reduces risk of JAK2V617F somatic mutation and myeloproliferative neoplasm: A Mendelian randomization study (2020) (17)
Protein-altering germline mutations implicate novel genes related to lung cancer development (2020) (17)
Is smoking heaviness causally associated with alcohol use? A Mendelian randomization study in four European cohorts (2018) (17)
Incidental lymphopenia and mortality: a prospective cohort study (2020) (17)
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma (2019) (16)
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility (2019) (16)
Genetic modifiers of CHEK 2 * 1100 delC-associated breast cancer risk (2017) (15)
Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study. (2020) (15)
Evidence that the 5 p 12 Variant rs 10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF 10 and MRPS 30 Regulation (15)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival (2015) (15)
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus (2016) (14)
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) (14)
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
AHRR ( cg 05575921 ) hypomethylation marks smoking behaviour , morbidity and mortality (2017) (14)
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (2012) (14)
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype (2005) (14)
Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies (2016) (13)
Cytochrome P450 1B1 and 2C9 genotypes and risk of ischemic vascular disease, cancer, and chronic obstructive pulmonary disease. (2012) (12)
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts (2020) (12)
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers (2021) (12)
Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification (2021) (11)
Properties and units in the clinical laboratory sciences. Part XVIII. Properties and units in clinical molecular biology (IUPAC Technical Report) (2004) (11)
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium (2017) (11)
Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes. (2005) (11)
Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk (2014) (11)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (10)
Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. (2020) (10)
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
Common Susceptibility Loci for Male Breast Cancer (2020) (9)
Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score. (2022) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
Risk of thyroid cancer, brain cancer, and non-Hodgkin lymphoma after adult leukemia: a nationwide study. (2011) (8)
JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing (2018) (8)
Genome‐wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk (2020) (8)
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma (2020) (8)
TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals (2017) (7)
Identification of New Biomarkers in Patients with Pancreatic Cancer (BIOPAC): A Study Protocol of an Open Cohort Study (2019) (7)
Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population. (2020) (7)
Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population (2016) (7)
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians (2022) (7)
Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses (2020) (7)
Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study. (2014) (7)
Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer (2019) (7)
Integrin &bgr;3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population (2007) (7)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population (2014) (6)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
Statin use and reduced cancer-related mortality. (2013) (6)
7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer (2019) (6)
AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival (2019) (6)
Burden of prediabetes, undiagnosed, and poorly or potentially sub-controlled diabetes: Lolland-Falster health study (2020) (5)
Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (5)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (5)
CYP2C9 genotype does not affect risk of tobacco-related cancer in the general population. (2010) (5)
AHRR (cg5575921) methylation safely improves specificity of lung cancer screening eligibility criteria: A cohort study. (2022) (5)
Integration of multiomic annotation data to prioritize and characterize inflammation and immune‐related risk variants in squamous cell lung cancer (2020) (5)
Physical activity and risk of instant and 28-day case-fatality in myocardial infarction (2019) (5)
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. (2019) (5)
Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis (2021) (4)
AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers. (2020) (4)
Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high‐risk myelodysplastic syndrome (2019) (4)
Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer (2021) (4)
Two-fold risk of pneumonia and respiratory mortality in individuals with myeloproliferative neoplasm: A population-based cohort study (2020) (4)
Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence (2021) (4)
Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study (2014) (4)
Incorporating progesterone receptor expression into the PREDICT breast prognostic model. (2022) (4)
Association of fatal myocardial infarction with past level of physical activity: a pooled analysis of cohort studies. (2021) (4)
Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy (2022) (3)
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Biomarker de-Mendelization: principles, potentials and limitations of a strategy to improve biomarker prediction by reducing the component of variance explained by genotype (2018) (3)
Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies. (2019) (3)
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population. (2011) (3)
Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
Self-reported and genetically predicted coffee consumption and smoking in dementia: A Mendelian randomization study. (2022) (3)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls (2020) (3)
Classification of Prostate Cancer Risk and Mortality (2013) (2)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function (2022) (2)
Fine-mapping identi fi es two additional breast cancer susceptibility loci at 9 q 31 . 2 (2015) (2)
Early-stage diagnosis of pancreatic cancer offers opportunity to improve overall patient survival (2016) (2)
Epigenetic regulation of PAR4-related platelet activation: mechanistic links between environmental exposure and cardiovascular disease (2018) (2)
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (2)
Increased Risk of Breast Cancer Associated With (2007) (2)
Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival. (2022) (2)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population (2021) (2)
Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer (2022) (2)
Two truncating variants in FANCC and breast cancer risk (2019) (2)
Reply from Authors re: Stacy Loeb. Use of Baseline Prostate-Specific Antigen Measurements to Personalize Prostate Cancer Screening. Eur Urol 2012;61:875–6 (2012) (2)
Measured and genetically predicted plasma YKL-40 levels and melanoma mortality. (2019) (2)
Early detection of lung cancer using cfDNA fragmentation. (2021) (2)
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk (2016) (2)
Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility (2016) (2)
Pretreatment plasma concentrations of YKL-40 and IL-6 in patients with pancreatic cancer: Potential diagnostic and prognostic biomarkers. (2013) (1)
Allostatic load as predictor of mortality: a cohort study from Lolland-Falster, Denmark (2022) (1)
Peripheral Mechanisms in Irritable Bowel Syndrome (2013) (1)
RESPONSE: Re: Integrin β3 Leu33Pro Homozygosity and Risk of Cancer (2004) (1)
Syddansk Universitet Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12 p 11 locus (2016) (1)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (1)
Plasma YKL-40 in Inuit and Danes. (2015) (1)
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) (1)
[C-reactive protein, risk of and survival after cancer--secondary publication]. (2009) (1)
Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm (2020) (1)
Chronic lymphocytic leukaemia clones are detectable decades before diagnosis (2021) (1)
Reference intervals for 12 clinical laboratory tests in a Danish population: The Lolland-Falster Health Study (2021) (1)
Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival (2022) (1)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium (2015) (1)
The prognostic value of serum CA 19-9 in patients with metastatic colorectal cancer. (2017) (1)
JAK2 V617F mutation positives in the general population. (2010) (1)
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk (2021) (1)
Integrin 3 Leu 33 Pro Homozygosity and Risk of Cancer (2003) (1)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: A Mendelian randomization study of 108,835 individuals (2022) (1)
Identi ﬁ cation of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk (2018) (1)
Authors’ response to Young and Hopkins: vitamin D and lung function (2014) (1)
Short t elomere l ength, c ancer Survival, and c ancer r isk in 47 102 i ndividuals (2013) (1)
Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue (2020) (1)
[Cancer patients should not be treated with statins. Reply]. (2013) (1)
Kidney function and risk of dementia: Observational study, meta-analysis, and two-sample mendelian randomization study (2022) (1)
Genetic Allelic Variation in the p53 DNA Repair Pathway Constitute a Risk Factor for Long-Term Survival in Hematopoietic Stem Cell Transplantation (2008) (1)
Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
Common breast cancer risk alleles and risk assessment: A study on 35,441 individuals from the Danish general population. (2016) (1)
3P-0845 Platelet glycoprotein IIb/IIIa P1A2/P1A2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men. The Copenhagen City Heart Study (2003) (1)
Iam hiQ—a novel pair of accuracy indices for imputed genotypes (2022) (1)
Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (1)
Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2 (2012) (1)
Platelet Glycoprotein IIb / IIIa PlA 2 / PlA 2 Homozygosity Associated With Risk of Ischemic Cardiovascular Disease and Myocardial Infarction in Young Men The Copenhagen City Heart Study (2016) (1)
sense Variants in ATM in 26 , 101 Breast Cancer B & P es and 29 , 842 Controls (2010) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. (2012) (0)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
OP-JNCI200057 329..337 (2021) (0)
Prognostic and diagnostic value of serum hyaluronan in patients with pancreatic carcinoma. (2018) (0)
Abstract 20071: Leisure-Time Physical Activity as a Predictor for Case Fatality in Acute Myocardial Infarction (2017) (0)
5179 POSTER Elevated Pre-treatment Levels of Plasma C-reactive Protein Are Associated With Poor Prognosis After Breast Cancer (2011) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Evaluation of C-reactive protein and YKL-40 as risk factors for incident cancer and early death after a diagnosis of cancer. (2010) (0)
GRAF (GTPase activating protein for Rho associated with FAK) (2011) (0)
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
1539P Signature protein biomarkers in serum for diagnosis of pancreatic ductal adenocarcinoma (2020) (0)
Pre-treatment serum 25-hydroxyvitamin D levels and survival in a Danish cohort of patients with pancreatic cancer (2019) (0)
Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk (2016) (0)
Nicotinic acetylcholine receptor polymorphism, smoking history, and tobacco-related cancer in the general population. (2010) (0)
Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer (2022) (0)
Smoking is an independent but not a causal risk factor for moderate to severe psoriasis: A Mendelian randomization study of 105,912 individuals (2023) (0)
Changing smoking behavior and epigenetics: a longitudinal study of 4,432 individuals from the general population. (2023) (0)
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model (2022) (0)
Cell-free DNA fragmentomes in the diagnostic evaluation of patients with symptoms suggestive of lung cancer. (2023) (0)
[Genomic medicine and cancer]. (2019) (0)
MicroRNA Biomarkers inWhole Blood for Detection of Pancreatic Cancer (2014) (0)
rs 2735383 , located at a microRNA binding site in the 3 ’ UTR of NBS 1 , is not associated with breast cancer risk (2016) (0)
Iam hiQ—a novel pair of accuracy indices for imputed genotypes (2022) (0)
Short t elomere length, cancer Sur vival, and cancer r isk in 47 1 02 individuals (2013) (0)
Protein-altering germline mutations implicate novel genes related to lung cancer development (2020) (0)
Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis (2022) (0)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
Common germline polymorphisms associated with breast cancer-specific survival (2015) (0)
Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for differen (2013) (0)
MLLT7 (myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7) (2011) (0)
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) (0)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals (2017) (0)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
Reply from Authors re: Ryan P. Kopp, Stephen J. Freedland, J. Kellogg Parsons. Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues. Eur Urol 2011;60:699–700 (2011) (0)
Abstract 2292: Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium (2017) (0)
Identi fi cation of susceptibility pathways for the role of chromosome 15 q 25 . 1 in modifying lung cancer risk (2018) (0)
Smoking does not accelerate leucocyte telomere attrition (2019) (0)
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) (0)
Combined Effects of Hormone Therapy, Alcohol Consumption and Body Mass Index in Relation to Postmenopausal Breast Cancer. (2014) (0)
AD51B in Familial Breast Cancer (2016) (0)
Null Results in Brief Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2009) (0)
Abstract 3871: Telomere length and cancer mortality and all-cause mortality (2015) (0)
The prognostic value of serum IL-6 and YKL-40 in patients with metastatic colorectal cancer. (2017) (0)
1405PDiagnostic analysis of patients referred from general practitioner with serious non-organ-specific symptoms and signs of cancer: A retrospective cohort study (2017) (0)
Gene-gene Interaction of AhR With and Within the Wnt Cascade Affects Susceptibility to Lung Cancer (2021) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk (2018) (0)
Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis (2023) (0)
Association of baseline c-reactive protein with incident cancer and survival in cancer patients. (2009) (0)
C-reaktivt protein, risiko for og overlevelse efter cancer--sekundaerpublikation (2009) (0)
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up (2022) (0)
Body mass index and breast cancer survival (2017) (0)
Response to the letter entitled: Re: Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer: Analysis of the prognostic effect of serum vitamin D on pancreatic cancer: Several confounders. (2021) (0)
Association of rs12662670 with breast cancer in Asian ER (2012) (0)
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival (2023) (0)
Abstract 570: Detecting cancer using genome-wide cfDNA nucleosomal fragmentation in a prospective multi cancer cohort (2021) (0)
Splice site mutations in mismatch repair genes and risk of cancer in the general population (2013) (0)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
Correction: Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer (2010) (0)
Shared heritability and functional enrichment across six solid cancers (2019) (0)
S279: INCREASED RISK OF INFECTIONS IN INDIVIDUALS WITH HEMOCHROMATOSIS C282Y HOMOZYGOSITY AND IN INDIVIDUALS WITH HIGH OR LOW PLASMA IRON OR TRANSFERRIN SATURATION: A PROSPECTIVE STUDY OF 138252 INDIVIDUALS (2022) (0)
Enhancing Diagnostic Evaluation of Patients with Symptoms of Lung Cancer Using the DELFI Circulating Cell-Free DNA Approach for Cancer Detection (2022) (0)
Clinical utility of plasma cell-free DNA in patients with pancreatic cancer. (2018) (0)
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (0)
Comment on: Integrin β3 Leu33Pro homozygosity and risk of cancer (2005) (0)
Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality (2019) (0)
Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (0)
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (0)
Allelic Variation in TP53 and MDM2 DNA Repair Genes Constitute Genetic Risk Factors for Long-Term Survival in Allogeneic Stem Cell Transplantation (2009) (0)
the Breast Cancer Association Consortium Five Polymorphisms and Breast Cancer Risk : Results from Updated (2009) (0)
I’am hiQ – A Novel Accuracy Index for Imputed Genotypes (2021) (0)
Diminishing benefits of urban living for children and adolescents’ growth and development (2023) (0)
Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity (2018) (0)
7102 ORAL Association of Benign Prostate Hyperplasia With Prostate Cancer Incidence and Mortality – a Nationwide Cohort Study (2011) (0)
The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
Self-reported and genetically predicted coffee and tobacco consumption in dementia (2020) (0)
CHEK2 in the Clinical Management of Breast Cancer (2008) (0)
Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer (2022) (0)
Splice site mutations in mismatch repair genes and risk of cancer in the general population (2013) (0)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus (2012) (0)
Development and validation of a simple general population lung cancer risk model including AHRR-methylation (2023) (0)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
Genetic variation in the immunosuppression pathway genes and breast cancer: a pooled analysis of 42,510 cases and 40,577 controls from the Breast (2015) (0)
Universitet AHRR ( cg 05575921 ) hypomethylation marks smoking behaviour , morbidity and mortality (2017) (0)
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
Platinum Priority Reply from (2013) (0)
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
Plasma vitamin D is not associated with moderate to severe psoriasis: results from Danish general population studies. (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stig Egil Bojesen?

Stig Egil Bojesen is affiliated with the following schools:

University of Copenhagen
Technical University of Munich
Karolinska Institute
University of Giessen
University of Cambridge
Leiden University
Aarhus University